Opioid-Induced Bowel Dysfunction

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drugs

• Publication date

  2012-12-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/11634970-000000000-00000PMID 22950533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rectal Hyposensitivity

  2012cited by this paper
• Transdermal Fentanyl

  2012cited by this paper
• Opioid-Induced Bowel Dysfunction

  2012cited by this paper
• Tramadol-induced oral dryness and pilocarpine treatment: effects on total protein and IgA.

  2011cited by this paper
• Gastrointestinal transit in patients with systemic sclerosis

  2011cited by this paper
• Isolated colonic inertia is not usually the cause of chronic constipation

  2011cited by this paper
• Validated tools for evaluating opioid-induced bowel dysfunction

  2011cited by this paper
• Interval Signet-Ring Cell Adenocarcinoma of the Colon: Missed or De Novo?

  2011cited by this paper
• Implementation of the victoria bowel performance scale.

  2011cited by this paper
• Lubiprostone for the treatment of opioid-induced bowel dysfunction

  2011cited by this paper
• Safety and Efficacy of Methylnaltrexone in Shortening the Duration of Postoperative Ileus Following Segmental Colectomy: Results of Two Randomized, Placebo-Controlled Phase 3 Trials

  2011cited by this paper
• Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride

  2011cited by this paper
• Novel opioid antagonists for opioid-induced bowel dysfunction

  2011cited by this paper
• The 'mystery' of opioid-induced diarrhea.

  2011cited by this paper
• Evaluation of efficacy and safety of fentanyl transdermal patch (Durogesic®D-TRANS) in chronic pain

  2010cited by this paper
• Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation – Quality of Life questionnaire in prucalopride (RESOLOR®) trials for chronic constipation

  2010cited by this paper
• Interstitial cells of Cajal, macrophages and mast cells in the gut musculature: morphology, distribution, spatial and possible functional interactions

  2010cited by this paper
• Reducing the gastrointestinal risks of low-dose aspirin.

  2010cited by this paper
• Do Stool Form and Frequency Correlate With Whole-Gut and Colonic Transit? Results From a Multicenter Study in Constipated Individuals and Healthy Controls

  2010cited by this paper
• Behavioural and new pharmacological treatments for constipation: getting the balance right

  2010cited by this paper
• Evidence for intestinal chloride secretion

  2010cited by this paper
• Opioid‐induced bowel disorders and narcotic bowel syndrome in patients with chronic non‐cancer pain

  2010cited by this paper
• Sacral nerve stimulation for intractable constipation

  2010cited by this paper
• Opiate‐induced oesophageal dysmotility

  2010cited by this paper
• Enteric nervous system: sensory physiology, diarrhea and constipation

  2010cited by this paper
• 906 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Lubiprostone for the Treatment of Opioid-Induced Bowel Dysfunction in Patients With Chronic, Non-Cancer Pain

  2010cited by this paper
• Methylnaltrexone and gastrointestinal perforation.

  2010cited by this paper
• Chronic constipation: overview and challenges

  2009cited by this paper
• Sphincter of Oddi: Function, dysfunction, and its management

  2009cited by this paper
• Pathophysiology of evacuation disorders

  2009cited by this paper
• Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study*

  2009cited by this paper
• The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).

  2009cited by this paper
• [Transdermal therapeutic systems for drug administration].

  2009cited by this paper
• Opioid Bowel Dysfunction and Narcotic Bowel Syndrome: A Population-Based Study

  2009cited by this paper
• Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

  2009cited by this paper
• Wireless Capsule Motility: Comparison of the SmartPill® GI Monitoring System with Scintigraphy for Measuring Whole Gut Transit

  2009cited by this paper
• Neuroanatomy and physiology of colorectal function and defaecation: from basic science to human clinical studies

  2009cited by this paper
• Gut peristalsis is governed by a multitude of cooperating mechanisms.

  2009cited by this paper
• Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation.

  2009cited by this paper
• Colonic movements in healthy subjects as monitored by a Magnet Tracking System

  2009cited by this paper
• Skin tolerability associated with transdermal drug delivery systems: an overview

  2009cited by this paper
• Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.

  2009cited by this paper
• Sudden severe abdominal pain after a single low dose of paracetamol/codein in a cholecystectomized patient: learning from a case report.

  2009cited by this paper
• Pathophysiology of colonic causes of chronic constipation

  2009cited by this paper
• Peripherally Acting Mu-Opioid Receptor Antagonists and Postoperative Ileus: Mechanisms of Action and Clinical Applicability

  2009cited by this paper
• Effectiveness of opioids in the treatment of chronic non-cancer pain.

  2008cited by this paper
• Methylnaltrexone for opioid-induced constipation in advanced illness.

  2008cited by this paper
• Methylnaltrexone for opioid-induced constipation in advanced illness.

  2008cited by this paper
• Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.

  2008cited by this paper
• Opioidinduzierte Obstipation: Literaturanalyse zu Pathophysiologie und Behandlung

  2008cited by this paper
• Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.

  2008cited by this paper
• The ORL-1 receptor system: are there opportunities for antagonists in pain therapy?

  2008cited by this paper
• Opioid-induced bowel dysfunction.

  2008cited by this paper
• The Constipation Severity Instrument: A Validated Measure

  2008cited by this paper
• Alvimopan, a peripherally acting mu‐opioid receptor (PAM‐OR) antagonist for the treatment of opioid‐induced bowel dysfunction: Results from a randomized, double‐blind, placebo‐controlled, dose‐finding study in subjects taking opioids for chronic non‐cancer pain

  2008cited by this paper
• Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus

  2008cited by this paper
• Gastrointestinal side effects in chronic opioid users: results from a population‐based survey

  2008cited by this paper
• Methylnaltrexone for opioid-induced constipation in advanced illness.

  2008cited by this paper
• FUNCTIONAL BOWEL DISORDERS

  2007cited by this paper
• Development and reliability testing of the Victoria Bowel Performance Scale (BPS).

  2007cited by this paper
• Dynamic MR defecography of the posterior compartment: Indications, techniques and MRI features.

  2007cited by this paper
• Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden

  2007cited by this paper
• Constipation: evaluation and treatment of colonic and anorectal motility disorders.

  2007cited by this paper
• Treatment of opioid-induced gut dysfunction

  2007cited by this paper
• Chronic constipation: a survey of the patient perspective

  2007cited by this paper
• Simultaneous assessment of the intraluminal pressure and transit time of the colon using a telemetry technique

  2007cited by this paper
• The morphine–prostigmine provocation (Nardi) test for sphincter of Oddi dysfunction: results in healthy volunteers and in patients before and after transduodenal sphincteroplasty and transampullary septectomy

  2007cited by this paper
• Chronic constipation: advances in management

  2007cited by this paper
• Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects

  2006cited by this paper
• The Adverse Effects of Morphine: A Prospective Survey of Common Symptoms During Repeated Dosing for Chronic Cancer Pain

  2006cited by this paper
• Rectal Hyposensitivity

  2006cited by this paper
• Validation of the PAC‐SYM questionnaire for opioid‐induced constipation in patients with chronic low back pain

  2006cited by this paper
• Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study.

  2005cited by this paper
• Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.

  2005cited by this paper
• Buprenorphine: considerations for pain management.

  2005cited by this paper
• Constipation management in palliative care: a survey of practices in the United kingdom.

  2005cited by this paper
• A new technique for evaluating sphincter function in visceral organs: application of the functional lumen imaging probe (FLIP) for the evaluation of the oesophago–gastric junction

  2005cited by this paper
• Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids

  2005cited by this paper
• Magnetic pill tracking: a novel non‐invasive tool for investigation of human digestive motility

  2005cited by this paper
• Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire

  2005cited by this paper
• Three‐dimensional biomechanical properties of the human rectum evaluated with magnetic resonance imaging

  2005cited by this paper
• Management of opioid-induced bowel dysfunction in cancer patients

  2004cited by this paper
• New probe for the measurement of dynamic changes in the rectum

  2004cited by this paper
• [Chronic constipation].

  2004cited by this paper
• The opioid system in the gastrointestinal tract

  2004cited by this paper
• Opioids in chronic non‐cancer pain: systematic review of efficacy and safety

  2004cited by this paper
• Preclinical studies of opioids and opioid antagonists on gastrointestinal function

  2004cited by this paper
• Assessing and managing opiate-induced constipation in adults with cancer.

  2004cited by this paper
• Function of opioids in the enteric nervous system

  2004cited by this paper
• Current concepts: Chronic constipation

  2003cited by this paper
• Effect of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide on Pancreatic, Hepatic and Duodenal Mucosal Bicarbonate Secretion in the Pig

  2003cited by this paper
• Biomechanics of the Gastrointestinal Tract

  2003cited by this paper
• Constipation: evaluation and treatment.

  2003cited by this paper
• Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?

  2002cited by this paper
• Management of Opioid‐Induced Gastrointestinal Effects in Patients Receiving Palliative Care

  2002cited by this paper
• Influence of naloxone on gastric emptying of solid meals, myoelectrical gastric activity and blood hormone levels in young healthy volunteers

  2002cited by this paper
• Electrolyte transport in the mammalian colon: mechanisms and implications for disease.

  2002cited by this paper
• Sphincter of Oddi dysfunction in patients addicted to opium: an unrecognized entity.

  2002cited by this paper
• Effect of an enteric‐release formulation of naloxone on intestinal transit in volunteers taking codeine

  2001cited by this paper
• Incidence, prevalence, and management of opioid bowel dysfunction.

  2001cited by this paper

• The Effect of Ropivacaine Combined with Dexmedetomidine for Erector Spinae Plane Block on the Postoperative Gastrointestinal Functional Recovery in Patients Undergoing Bariatric Surgery

  2026cites this paper
• Assessment of Antidiarrheal Activity of Fraxin in Chick: Synergistic Effects and Molecular Docking Study

  2026cites this paper
• Oral rehydration solution for the management of fluid and electrolyte disturbances in patients with an ileostomy: A scoping review.

  2026cites this paper
• Intestinal barrier damage caused by addictive substance use disorder

  2025cites this paper
• Optimising Pain Relief in Acute Pancreatitis: An Evidence-Based Approach

  2025cites this paper
• A brain-to-small intestine circuit mediates morphine-induced constipation in male mice

  2025cites this paper
• Effect of thoracic paravertebral block and erector spinae plane block on postoperative gastrointestinal function and quality of recovery in patients undergoing thoracoscopic lobectomy: a randomized controlled trial

  2025cites this paper
• Opioid induced constipation: mechanisms and management.

  2025cites this paper
• Risk factors for postoperative ileus following transforaminal lumbar interbody fusion: a retrospective study

  2025cites this paper
• Peripheral inflammation enhances opioid-induced gastrointestinal motility inhibition via up-regulating spinal mu opioid receptor.

  2025cites this paper
• Opioids induce constipation by prompting alpha-Synuclein hyperphosphorylation in the colonic myenteric plexus.

  2025cites this paper
• Naldemedine for the management of opioid-induced constipation in patients with cancer pain: A narrative review

  2025cites this paper
• Bilateral Rectus Sheath Block with Continuous Bupivacaine Infusions After Elective Open Gastrectomy: A Randomized Controlled Trial

  2024cites this paper
• The influence of tramadol on bowel function: A randomised, placebo‐controlled trial

  2024cites this paper
• Prescription opioids induced microbial dysbiosis worsens severity of chronic pancreatitis and drives pain hypersensitivity

  2024cites this paper
• A Systematic Review of Naldemedine and Naloxegol for the Treatment of Opioid-Induced Constipation in Cancer Patients

  2024cites this paper
• Diet-ODIN: A Novel Framework for Opioid Misuse Detection with Interpretable Dietary Patterns

  2024cites this paper
• Opioid-induced Constipation: Old and New Concepts in Diagnosis and Treatment.

  2024cites this paper
• Neurological disorders leading to mechanical dysfunction of the esophagus: an emergent behavior of a neuromechanical dynamical system.

  2024cites this paper
• Opioid-induced bowel dysfunction: a literature review

  2023cites this paper
• Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis

  2023cites this paper
• Naldemedine-induced opioid withdrawal with restlessness as the predominant symptom in a palliative care setting.

  2023cites this paper
• EVALUATION OF THE EFFECT OF THE AQUEOUS EXTRACT OF THE RECIPE MADE FROM THE LEAVES OF OCIMUM GRATISSIMUM. LINN (LAMIACEAE) AND TERMINALIA SUPERBA STEAM BARK. ENGL (COMBREATACEAE) ON LOPERAMIDE-INDUCED CONSTIPATION

  2023cites this paper
• Kidney Donor Perspectives on Acute Postoperative Pain Management

  2023cites this paper
• Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation

  2023cites this paper
• Ultrasound-Guided Blocks for Spine Surgery: Part 1—Cervix

  2023cites this paper
• The Effect of Intravenous Metoclopramide on Gastric Emptying of Opium-dependent Patients based on Ultrasonographic Criteria; a Case-control Study

  2023cites this paper
• Rubiscolin-6 rapidly suppresses the postprandial motility of the gastric antrum and subsequently increases food intake via δ-opioid receptors in mice

  2022cites this paper
• Oxycodone-Naloxone Combination Hinders Opioid Consumption in Osteoarthritic Chronic Low Back Pain: A Retrospective Study with Two Years of Follow-Up

  2022cites this paper
• Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System

  2022cites this paper
• ANALYSIS OF POST-TRAUMATIC DYNAMICS OF MINERAL COMPOSITION OF BONE TISSUE IN INTACT ANIMALS ON THE BACKGROUND OF THE PROLONGED NALBUFINUM USE AND AFTER LINCOMYCIN TREATMENT

  2022cites this paper
• Epidural Anesthesia with Opioids in Open Colorectal Surgeries is not Related to Postoperative Ileum

  2022cites this paper
• Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology.

  2021cites this paper
• Can Naloxegol Therapy Improve Quality of Life in Patients with Advanced Cancer?

  2021cites this paper
• Association between preoperative administration of gabapentinoids and 30-day hospital readmission: A retrospective hospital registry study.

  2021cites this paper
• The Ameliorative Effects of Isorhynchophylline on Morphine Dependence Are Mediated Through the Microbiota-Gut-Brain Axis

  2021cites this paper
• Validity and Reliability of the Hindi Version of the Patient Assessment of Constipation Quality of Life Questionnaire in Cancer Patients on Opioids for Pain Management at Tertiary Care Center, India

  2021cites this paper
• Incidence and Factors of Prolonged Postoperative Ileus in Gastric Cancer Surgery

  2021cites this paper
• Прогнозирование фентанил-ассоциированной нейротоксичности у больных с раком поджелудочной железы с помощью клинико-генетической модели

  2021cites this paper
• Total pancreatectomy with islet autotransplantation – a new pain management strategy in chronic pancreatitis?

  2021cites this paper
• Retrospective evaluation of maropitant and perioperative factors affecting postoperative appetite in cats.

  2021cites this paper
• Overlap and cumulative effects of pancreatic duct obstruction, abnormal pain processing and psychological distress on patient-reported outcomes in chronic pancreatitis

  2021cites this paper
• Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations

  2021cites this paper
• Postoperative ileus: A pharmacological perspective

  2021cites this paper
• Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel

  2021cites this paper
• Fetal gastric area ratio to predict severe neonatal opioid withdrawal syndrome

  2021cites this paper
• A randomized controlled trial of the effect of ramosetron on postoperative restoration of bowel motility after gynecologic laparoscopic surgery

  2021cites this paper
• Predicting of fentanyl-associated neurotoxicity in pancreatic cancer with clical, genetic model

  2021cites this paper
• Pain Management in Chronic Pancreatitis: Summary of Clinical Practice, Current Challenges and Potential Contribution of the M-ANNHEIM Classification

  2021cites this paper
• Effects of codeine on esophageal peristalsis in humans using high resolution manometry

  2021cites this paper
• Gastrointestinal dysmotility in a patient with advanced lung cancer: paraneoplastic or drug-induced?

  2021cites this paper
• Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers

  2021cites this paper
• Psychopharmacologic Therapies for Irritable Bowel Syndrome.

  2021cites this paper
• EVALUATION OF THE INTEGRATION OF ACETAMINOPHEN AND DEXMEDETOMIDINE IN THE CARDIAC SURGERY POPULATION: IMPACT ON THE AMOUNT OF PRESCRIBED OPIOIDS, RESPIRATORY AND CARDIOVASCULAR OUTCOMES

  2020cites this paper
• Gastrointestinal pain

  2020cites this paper
• The role of naldemedine in the treatment of opioid-induced constipation

  2020cites this paper
• Personalized modeling of opioid-associated constipation in patients with pancreatic cancer

  2020cites this paper
• Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients

  2020cites this paper
• Codeine induces increased resistance at the esophagogastric junction but has no effect on motility and bolus flow in the pharynx and upper esophageal sphincter in healthy volunteers: A randomized, double‐blind, placebo‐controlled, cross‐over trial

  2020cites this paper
• Pharmacokinetics and pharmacodynamics of meperidine after intramuscular and subcutaneous administration in horses.

  2020cites this paper
• Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation

  2020cites this paper
• Pancreatic QST Differentiates Chronic Pancreatitis Patients into Distinct Pain Phenotypes Independent of Psychiatric Comorbidities.

  2020cites this paper
• Design, Synthesis and Functional Analysis of Cyclic Opioid Peptides with Dmt-Tic Pharmacophore

  2020cites this paper
• Creating a bowel management plan for pediatric orthopaedic spine surgery patients

  2020cites this paper
• Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study

  2020influential citation
• Prise en charge de la constipation induite par les opioïdes : regards croisés d’un gastroentérologue et d’un médecin de la douleur

  2020cites this paper
• Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a Mu Opioid Receptor Agonist/Delta Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.

  2020cites this paper
• The search for opioid analgesics with limited tolerance liability.

  2020cites this paper
• Naldemedine for the Use of Management of Opioid Induced Constipation.

  2020cites this paper
• Codeine delays gastric emptying through inhibition of gastric motility as assessed with a novel diagnostic intragastric balloon catheter

  2020cites this paper
• Evaluating naloxegol for the treatment of opioid-induced constipation

  2020cites this paper
• A systematic review on dietary interventions to reduce postoperative ileus: coffee and chewing gum

  2020cites this paper
• A retrospective evaluation of the effect of perianesthetic hydromorphone administration on the incidence of postanesthetic signs of colic in horses.

  2020cites this paper
• Depletion of the Microbiome Alters the Recruitment of Neuronal Ensembles of Oxycodone Intoxication and Withdrawal

  2020cites this paper
• Assessing and Managing Opioid-Related Side Effects in Children and Adolescents

  2020cites this paper
• Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment

  2019cites this paper
• Biased agonism as an emerging strategy in the search for better opioid analgesics.

  2019cites this paper
• Discovery of Axelopran (TD-1211): A Peripherally Restricted μ-Opioid Receptor Antagonist.

  2019cites this paper
• Regional gastrointestinal transit times in patients with chronic pancreatitis

  2019cites this paper
• Impact of thoracic paravertebral block combined with general anesthesia on postoperative cognitive function and serum adiponectin levels in elderly patients undergoing lobectomy

  2019cites this paper
• The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses.

  2019cites this paper
• Pharmacokinetics and pharmacodynamics of hydromorphone after intravenous and intramuscular administration in horses.

  2019cites this paper
• Opioid-induced constipation: a narrative review of therapeutic options in clinical management

  2019cites this paper
• Opioid-Induced Constipation in Oncological Patients: New Strategies of Management

  2019cites this paper
• MRI analysis of fecal volume and dryness: Validation study using an experimental oxycodone‐induced constipation model

  2019cites this paper
• Novel synthetic opioids: A review of the literature

  2019cites this paper
• Irritable Bowel Syndrome and Constipation Agents

  2019cites this paper
• Treating opioid‐induced constipation in patients taking other medications: Avoiding CYP450 drug interactions

  2019cites this paper
• A Clinical Feasible Method for Computed Tomography-Based Assessment of Sarcopenia in Patients With Chronic Pancreatitis.

  2019cites this paper
• Pathophysiology and management of opioid-induced constipation: European expert consensus statement

  2019cites this paper
• Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system: Effect of opioids

  2019cites this paper
• Peripherally acting μ‐opioid antagonist for the treatment of opioid‐induced constipation: Systematic review and meta‐analysis

  2019cites this paper
• Mechanism-based pain management in chronic pancreatitis – is it time for a paradigm shift?

  2019cites this paper
• Effects of Naloxegol on Gastrointestinal Transit and Colonic Fecal Volume in Healthy Participants Receiving Oxycodone

  2019cites this paper
• The role of naldemedine in the treatment of patients with opioid-induced constipation

  2019influential citation
• Fostering Best Practices for Reducing Opioid-Induced Constipation Using Technology.

  2019cites this paper
• Roux Limb Motility in Gastric Bypass Patients with Chronic Abdominal Pain-Is There an Association to Prescribed Opioids?

  2019cites this paper
• The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation

  2019cites this paper
• Constipation in Critically Ill Patients : What Nurse Practitioner Should Know

  2019cites this paper
• DENSITY AND MINERAL CONTENT DYNAMICS OF BONE TISSUE AGAINST THE BACKGROUND OF OPIOID INFLUENCE

  2019cites this paper